Yüklüyor......
Gene editing and gene-based therapeutics for cardiomyopathies
With an increasing understanding of genetic defects leading to cardiomyopathy, focus is shifting to methods for correcting these underlying genetic defects. One approach involves treating mutant RNA through antisense oligonucleotides, and the first drug has now received regulatory approval to treat...
Kaydedildi:
| Yayımlandı: | Heart Fail Clin |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849064/ https://ncbi.nlm.nih.gov/pubmed/29525646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hfc.2017.12.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|